Polyrizon (PLRZ) Stock Price, News & Analysis

Company Overview

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.

Key Stats

• Today's Range: $0.31 to $0.36
• 50-Day Range: $0.32 to $1.08
• 52-Week Range: $0.28 to $4.80
• Volume: 4.75 million shs
• Average Volume: 351,372 shs
• Market Capitalization: $1.43 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PLRZ Stock Analysis - Frequently Asked Questions

How have PLRZ shares performed this year?

Polyrizon's stock was trading at $2.17 at the beginning of 2025. Since then, PLRZ stock has decreased by 84.3% and is now trading at $0.34.
View the best growth stocks for 2025 here.

When did Polyrizon IPO?

Polyrizon (PLRZ) raised $4 million in an initial public offering on Tuesday, October 29th 2024. The company issued 958,903 shares at $4.38 per share.

When does Polyrizon's lock-up period expire?

Polyrizon's lock-up period expires on Monday, April 28th. Polyrizon had issued 958,903 shares in its initial public offering on October 29th. The total size of the offering was $4,199,995 based on an initial share price of $4.38. After the end of Polyrizon's lock-up period, company insiders and major shareholders will be able to sell their shares of the company.

How do I buy shares of Polyrizon?

Shares of PLRZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 4/26/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:PLRZ
• Previous Symbol: NASDAQ:PLRZ
• CIK: 1893645
• Web: www.polyrizon-biotech.com
• Phone: 972-55-433-5665
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 4,194,000
• Free Float: N/A
• Market Cap: $1.43 million
• Optionable: N/A
• Beta: N/A